ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Wynder, Doll, Hill Share Ochsner Award

September 23, 1988

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

NCI Reorganization: DEC Epidemiology Stays In Place, DCPC To Build Its Own – No Decision Yet Enters, Other DCPC Program – CIS Moved To OCC, ICIC ut Of OIA

June 24, 1988